A subgroup of DLBCL patients within the GCB-DLBCL subtype with dual MYC and BCL2 rearrangements, representing 5% to 10% of cases, has the worst prognosis [18]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.